• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骶髂关节SPARCC评分的度量属性——来自SPACE队列基线、3个月和12个月随访的数据。

Metric Properties of the SPARCC Score of the Sacroiliac Joints - Data from Baseline, 3-month, and 12-month Followup in the SPACE Cohort.

作者信息

van den Berg Rosaline, de Hooge Manouk, Bakker Pauline A C, van Gaalen Floris, Navarro-Compán Victoria, Fagerli Karen Minde, Landewé Robert, van Oosterhout Maikel, Ramonda Roberta, Reijnierse Monique, van der Heijde Désirée

机构信息

From the Department of Rheumatology, and the Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands; Department of Rheumatology, University Hospital La Paz, Madrid, Spain; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway; Amsterdam Rheumatology Center, Amsterdam; Department of Rheumatology, Groene Hart Ziekenhuis (GHZ) hospital, Gouda, the Netherlands; Rheumatology Unit, Department of Medicine, DIMED University of Padua, Padua, Italy.R. van den Berg, PhD; M. de Hooge, MSc; P.A. Bakker, MD; F. van Gaalen, MD, PhD, Department of Rheumatology, Leiden University Medical Center; V. Navarro-Compán, MD, Department of Rheumatology, Leiden University Medical Center, and Department of Rheumatology, University Hospital La Paz; K.M. Fagerli, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; R. Landewé, MD, PhD, Amsterdam Rheumatology Center; M. van Oosterhout, MD, PhD, Department of Rheumatology, GHZ hospital; R. Ramonda, MD, Rheumatology Unit, Department of Medicine, DIMED University of Padua; M. Reijnierse, MD, PhD, Department of Radiology, Leiden University Medical Center; D. van der Heijde, MD, PhD, Department of Rheumatology, Leiden University Medical Center.

出版信息

J Rheumatol. 2015 Jul;42(7):1186-93. doi: 10.3899/jrheum.140806. Epub 2015 May 1.

DOI:10.3899/jrheum.140806
PMID:25934824
Abstract

OBJECTIVE

To evaluate metric properties of the SpondyloArthritis Research Consortium of Canada (SPARCC) score of the sacroiliac (SI) joints.

METHODS

Patients with back pain (≥ 3 months, ≤ 2 years, onset < 45 years) were included in the SPACE cohort (SpondyloArthritis Caught Early). Patients with (possible) axial spondyloarthritis had followup visits after 3 and 12 months and were treated according to clinical practice. Magnetic resonance imaging (MRI) of the SI joints (MRI-SI) was scored in 2 independent campaigns (campaign 1: at baseline and 3 months; campaign 2: at baseline, 3 months, and 12 months) by 2 different blinded reader pairs, applying the Assessment of Spondyloarthritis International Society (ASAS) definition (MRI-SI+ vs MRI-SI-; discordant cases were adjudicated by a third reader) and SPARCC score (mean of 2 agreeing readers). Calculations were made for agreement between SPARCC score cutoff values and a consensus judgment of MRI-SI+ (ASAS definition) as external standard, change in SPARCC score, and smallest detectable changes (SDC) over 3 and 12 months.

RESULTS

SPARCC score ≥ 2 showed best agreement with MRI-SI+ in both campaigns. Regarding observed changes in relation to SDC, SPARCC score changed in 70/151 patients; 26/70 patients changed > SDC (3.4), of whom 20 patients received stable treatment over 3 months in campaign 1. Over 3 months, 20/68 patients showed changes in SPARCC score; 11/20 > SDC (2.1), of whom 8 patients received stable treatment. Over 1 year, 23/74 patients changed their SPARCC score; 14/23 changed > SDC (2.4), of whom 7 received stable treatment in campaign 2.

CONCLUSION

SPARCC score ≥ 2 can be used as surrogate for a consensus judgment of MRI-SI+ (ASAS definition) in clinical trials. The SDC ranged from 2.1-3.4 dependent on reader pair and were close to the proposed minimum important change of 2.5.

摘要

目的

评估加拿大脊柱关节炎研究联盟(SPARCC)骶髂关节评分的测量属性。

方法

背痛患者(≥3个月,≤2年,发病年龄<45岁)纳入SPACE队列研究(早期发现的脊柱关节炎)。(可能的)轴性脊柱关节炎患者在3个月和12个月后进行随访,并根据临床实践进行治疗。由2组不同的盲法阅片者对骶髂关节磁共振成像(MRI-SI)进行评分(第1次:基线和3个月时;第2次:基线、3个月和12个月时),采用国际脊柱关节炎评估协会(ASAS)的定义(MRI-SI+与MRI-SI-;不一致的病例由第三位阅片者判定)和SPARCC评分(2位阅片者一致评分的平均值)。计算SPARCC评分临界值与以MRI-SI+的共识判断(ASAS定义)作为外部标准之间的一致性、SPARCC评分的变化以及3个月和12个月期间的最小可检测变化(SDC)。

结果

在两次研究中,SPARCC评分≥2与MRI-SI+的一致性最佳。关于观察到的相对于SDC的变化,151例患者中有70例SPARCC评分发生变化;70例患者中有26例变化>SDC(3.4),其中20例患者在第1次研究的3个月内接受稳定治疗。3个月内,68例患者中有20例SPARCC评分发生变化;20例中有11例变化>SDC(2.1),其中8例患者接受稳定治疗。1年内,74例患者中有23例SPARCC评分发生变化;23例中有14例变化>SDC(2.4),其中7例在第2次研究中接受稳定治疗。

结论

在临床试验中,SPARCC评分≥2可作为MRI-SI+(ASAS定义)共识判断的替代指标。SDC范围为2.1-3.4,取决于阅片者组,且接近提议的最小重要变化值2.5。

相似文献

1
Metric Properties of the SPARCC Score of the Sacroiliac Joints - Data from Baseline, 3-month, and 12-month Followup in the SPACE Cohort.骶髂关节SPARCC评分的度量属性——来自SPACE队列基线、3个月和12个月随访的数据。
J Rheumatol. 2015 Jul;42(7):1186-93. doi: 10.3899/jrheum.140806. Epub 2015 May 1.
2
Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods.评估方法为柏林标准和加拿大脊柱关节炎研究协会标准:在随机、双盲、安慰剂对照的丹麦阿达木单抗治疗脊柱关节炎多中心研究中,磁共振成像检测到的骶髂关节炎症和结构损伤的病程。
Arthritis Rheumatol. 2016 Feb;68(2):418-29. doi: 10.1002/art.39434.
3
Magnetic Resonance Imaging of the Sacroiliac Joints Indicating Sacroiliitis According to the Assessment of SpondyloArthritis international Society Definition in Healthy Individuals, Runners, and Women With Postpartum Back Pain.健康个体、跑步者和产后腰痛女性的骶髂关节磁共振成像根据脊柱关节炎国际学会的定义评估显示骶髂关节炎。
Arthritis Rheumatol. 2018 Jul;70(7):1042-1048. doi: 10.1002/art.40475. Epub 2018 May 23.
4
Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints.简要报告:非甾体抗炎药最佳剂量治疗中轴型脊柱关节炎患者 6 周:骶髂关节磁共振成像信号强度的早期治疗反应。
Arthritis Rheumatol. 2016 Mar;68(3):672-8. doi: 10.1002/art.39474.
5
Validation of whole-body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis.全身成像与传统磁共振成像用于对脊柱关节炎患者骶髂关节急性炎症性病变进行评分的验证
Arthritis Rheum. 2009 Jul 15;61(7):893-9. doi: 10.1002/art.24542.
6
Defining the Minimally Important Change for the SpondyloArthritis Research Consortium of Canada Spine and Sacroiliac Joint Magnetic Resonance Imaging Indices for Ankylosing Spondylitis.定义加拿大脊柱关节炎研究联合会脊柱和骶髂关节磁共振成像指数用于强直性脊柱炎的最小重要变化。
J Rheumatol. 2012 Aug;39(8):1666-74. doi: 10.3899/jrheum.120131. Epub 2012 Jul 1.
7
Magnetic Resonance Imaging of Lesions in the Sacroiliac Joints for Differentiation of Patients With Axial Spondyloarthritis From Control Subjects With or Without Pelvic or Buttock Pain: A Prospective, Cross-Sectional Study of 204 Participants.骶髂关节病变的磁共振成像对区分伴或不伴骨盆或臀部疼痛的中轴型脊柱关节炎患者与对照组的作用:204 例参与者的前瞻性、横断面研究。
Arthritis Rheumatol. 2019 Dec;71(12):2034-2046. doi: 10.1002/art.41037. Epub 2019 Oct 29.
8
Development and preliminary validation of the spondyloarthritis research consortium of Canada magnetic resonance imaging sacroiliac joint structural score.加拿大脊柱关节炎研究联盟磁共振成像骶髂关节结构评分的开发与初步验证
J Rheumatol. 2015 Jan;42(1):79-86. doi: 10.3899/jrheum.140519. Epub 2014 Oct 15.
9
Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment.通过磁共振成像对强直性脊柱炎脊柱炎症活动进行评分:一项多阅片者实验
J Rheumatol. 2007 Apr;34(4):862-70.
10
Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.通过磁共振成像对骶髂关节进行评分。一项多阅片者可靠性实验。
J Rheumatol. 2005 Oct;32(10):2050-5.

引用本文的文献

1
Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis.在活动性中轴型脊柱关节炎患者中,探究性分析培塞丽珠单抗治疗后客观炎症反应与临床反应之间潜在的脱钩现象。
RMD Open. 2024 Aug 28;10(3):e004369. doi: 10.1136/rmdopen-2024-004369.
2
Changes of inflammation in patients with psoriatic arthritis after high intensity interval training assessed by ultrasound and MRI, a randomized controlled trial.超声和磁共振成像评估高强度间歇训练对银屑病关节炎患者炎症变化的影响:一项随机对照试验。
BMC Musculoskelet Disord. 2023 Sep 19;24(1):743. doi: 10.1186/s12891-023-06871-3.
3
Can radiomics replace the SPARCC scoring system in evaluating bone marrow edema of sacroiliac joints in patients with axial spondyloarthritis?
放射组学能否取代 SPARCC 评分系统评估中轴型脊柱关节炎患者骶髂关节骨髓水肿?
Clin Rheumatol. 2023 Jun;42(6):1675-1682. doi: 10.1007/s10067-023-06543-6. Epub 2023 Feb 16.
4
Use of Imaging in Axial Spondyloarthritis for Diagnosis and Assessment of Disease Remission in the Year 2022.2022 年影像学在中轴型脊柱关节炎的诊断和疾病缓解评估中的应用。
Curr Rheumatol Rep. 2022 Dec;24(12):383-397. doi: 10.1007/s11926-022-01091-5. Epub 2022 Oct 15.
5
Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.使用加拿大脊柱关节炎研究联合会评分系统评估中轴型脊柱关节炎的骶髂关节炎的活动性炎症、慢性结构损伤和治疗反应。
BMC Musculoskelet Disord. 2022 Jul 8;23(1):654. doi: 10.1186/s12891-022-05609-x.
6
Efficacy and Safety of Wenbu Zhibi Granule in Patients with Ankylosing Spondylitis: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.温补肾痹颗粒治疗强直性脊柱炎患者的疗效与安全性:一项多中心、随机、双盲、安慰剂对照试验
Evid Based Complement Alternat Med. 2021 Nov 25;2021:8683600. doi: 10.1155/2021/8683600. eCollection 2021.
7
Changes over time in inflammatory and structural lesions at the sacroiliac joint in children with spondyloarthritis exposed and unexposed to tumor necrosis factor inhibitor.在接受和未接受肿瘤坏死因子抑制剂治疗的儿童中,脊柱关节炎患者骶髂关节炎症和结构病变的随时间变化。
Pediatr Rheumatol Online J. 2021 Dec 2;19(1):167. doi: 10.1186/s12969-021-00647-6.
8
Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis.靶向白细胞介素-23/白细胞介素-17 炎症通路:治疗中轴型脊柱关节炎的成败。
Front Immunol. 2021 Sep 3;12:715510. doi: 10.3389/fimmu.2021.715510. eCollection 2021.
9
Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial).在活动性强直性脊柱炎患者中,12 周时 fingolimod 对骶髂关节磁共振成像结构病变的影响( TORTUGA 试验)。
Rheumatology (Oxford). 2022 May 5;61(5):2063-2071. doi: 10.1093/rheumatology/keab543.
10
Spine and Sacroiliac Joints Lesions on Magnetic Resonance Imaging in Early Axial-Spondyloarthritis During 24-Months Follow-Up (Italian Arm of SPACE Study).脊柱和骶髂关节磁共振成像在 24 个月随访中早期中轴型脊柱关节炎的病变(SPACE 研究意大利分支)。
Front Immunol. 2020 May 15;11:936. doi: 10.3389/fimmu.2020.00936. eCollection 2020.